Q3 2025 Earnings Call Transcript November 10, 2025 CoreWeave, Inc. Class A Common Stock beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.3962. Operator: Thank you for ...

THE WOODLANDS, Texas, Nov. 12, 2025 (GLOBE NEWSWIRE) -- TWFG, Inc. ("TWFG”, the "Company” or "we”) (NASDAQ: TWFG), a ...

Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end 2025 - - Reported highly positive 12-week primary endpoint results from Phase 2 ...

Financial Assets ~~ Second Consecutive Quarter of Positive Operating Cash Flow ~~ Poised to Further Fulfill Mergers and ...

Lead candidate from mutant selective JAK2V617F JH2 inhibitor program advancing with IND filing expected in the first quarter of 2026Lead ...

In the third quarter of 2025, tons sold totaled approximately 1,472,000, compared to 1,424,000 tons in the second quarter of ...

Transformational quarter puts Envoy Medical in significantly better position as it eliminated $32 million of debt, strengthened its balance sheet, and further expanded its patent ...

Announced new clinical trial agreement with Pfizer to evaluate palazestrant in combination withatirmociclib in ER+/HER2- metastatic breast cancerInitiated OPERA-02 Phase 3 trial of palazestrant in ...

Detailed price information for Onkure Therapeutics Inc (OKUR-Q) from The Globe and Mail including charting and trades.

For the three months ended September 30 For the nine months ended September 30 US$ millions (except per unit amounts), unaudited1 2025 2024 2025 2024 Net income (loss) 2 $ 440 $ (52 ) $ 634 $ 126 – ...

Annualized recurring revenue ("ARR") of $838 million, an increase of 2% year-over-yearTotal revenue of $218 million, up 2% year-over-year; Product subscriptions revenue of $210 million, up 2% year-ove ...

Hawaiian Electric’s net income for the third quarter of 2025 was $37 million compared to a net loss of $83 million in the third quarter of 2024, with the increase primarily driven by the following pre ...